2021 corporate social responsibility report Jenkem Technology Co.Ltd(688356) report description report data description
The data range of this report is from January 1 to December 31, 2021, and some contents are beyond the above time range. The financial data in this report are from Jenkem Technology Co.Ltd(688356) 2021 annual report, and other data are from third-party institutions and the company’s own statistical system. Report scope this report covers Jenkem Technology Co.Ltd(688356) and its wholly-owned subsidiaries. In the text, ” Jenkem Technology Co.Ltd(688356) ,” Jiankai “and” company “refer to” Jenkem Technology Co.Ltd(688356) “and its wholly-owned subsidiaries. The preparation of the report is based on the relevant requirements of the guidelines for corporate social responsibility reporting in China (cass-csr4.0) issued by the Chinese Academy of Social Sciences and the guidelines for environmental information disclosure of Listed Companies in Shanghai Stock Exchange issued by Shanghai Stock Exchange. Report release form this report is published in electronic form and can be consulted on the official websites of Shanghai Stock Exchange and the company. The company plans to issue the corporate social responsibility report once a year. Contact information Jenkem Technology Co.Ltd(688356) website: www.jenkem.com com. Address: floor 3, C1, Northern Territory, Dongsheng science and Technology Park, No. 66, xixiaokou Road, Haidian District, Beijing zip code: 100192 Tel.: 01082893760 email: [email protected].
The chairman of the board of directors sent a message to the key heart, and Kaifeng came from scratch
After 20 years of development, on August 26, 2020, Jenkem Technology Co.Ltd(688356) successfully landed on the scientific innovation board of Shanghai Stock Exchange and was recognized by the capital market. Listing means new development opportunities and greater social responsibility. Taking the opportunity of landing in the capital market, the company never forgets its original intention and strives to forge ahead. Through capital assistance and careful implementation of raised investment projects, the company further improves its comprehensive strength and never forgets its original intention, and is committed to building Jenkem Technology Co.Ltd(688356) into a leading innovative enterprise in the field of medical polyethylene glycol in the world.
Since 2020, covid-19 epidemic, as the most important public health emergency in the world, has had an extremely profound impact on the macro-economy and even the world pattern. As an upstream supplier closely related to the pharmaceutical industry, we try our best to eliminate the impact of the epidemic and ensure stable supply. In view of the changes in downstream demand since the epidemic, we have also adjusted the product R & D plan in time, quickly launched products in line with the world’s cutting-edge technology direction, and provided assistance for public health and biomedical industry in a down-to-earth, responsible and efficient spirit. In the summer of 2021, facing the flood disaster caused by rare heavy rainfall weather in Henan Province, Jenkem Technology Co.Ltd(688356) loved the victims, actively provided relief materials, supported the post disaster reconstruction of the affected villages and helped the affected people recover their normal production and life as soon as possible.
As a high-tech enterprise with a sense of social responsibility, we deeply agree with the development idea of “green water and green mountains are golden mountains and silver mountains”, and implement the green concept in all aspects of R & D and production. By continuously optimizing the production process, carrying out energy conservation, emission reduction and pollution control in a scientific way, we have always reduced our holdings and operated in compliance, built a garden factory, and are committed to obtaining the highest production value with the lowest resource consumption and emission Jenkem Technology Co.Ltd(688356) in the future, we should not only become the leader of medical polyethylene glycol material industry, but also become the practitioner and advocate of green concept.
In 2021, we will continue to optimize the corporate governance system, improve the internal control system, strictly control the compliance of information disclosure, and continuously improve ourselves in standardizing the company’s operation, preventing corporate risks and protecting the rights and interests of investors; In addition, the first phase of equity incentive plan was launched to stimulate the vitality of enterprises and employees. Since the listing, in order to adapt to the change of the company’s role from a listed company to a listed company and meet the needs of the new era, we have put forward a new corporate culture and strategic system, updated the company’s corporate vision, mission and values, took “material innovation leading biomedical innovation” as the mission, and adhered to the spirit of “continuous innovation, determined development, respect for science and respect for talents” to help the company achieve its strategic objectives. I will work together with all Jiankai people, take the field of Pan polyethylene glycol materials as the core, strive to realize China’s international double cycle, double drive of material sales and technical services, help the biomedical industry and protect the health of all mankind.
In 2021, we always adhere to the concept of “people-oriented”, give back to the society and actively undertake corporate social responsibility. The company cares about every employee, puts health and safety in the first place, establishes a warm, targeted and centripetal team, and promotes common growth with employees through training and learning. We continue to actively participate in the construction of industrial regulations, standards and norms, cooperate with downstream industries, actively communicate and promote each other.
In 2022, Jenkem Technology Co.Ltd(688356) decided to take the fulfillment of social responsibility as an important part of the long-term sustainable development strategy of the enterprise, so as to better shoulder the mission and responsibility entrusted to us by the times. Where the heart of the key comes, the triumph comes from itself Jenkem Technology Co.Ltd(688356) , we will strive to realize our vision, complete the mission of leading biomedical innovation with material innovation, do a good job in the enterprise and give back to the society with love.
Jenkem Technology Co.Ltd(688356) chairman and general manager
Enter key Kay 1 key Kai culture 2 Jenkem Technology Co.Ltd(688356) social responsibility management system three
Analysis of substantive issues and participation of relevant stakeholders 3 report preparation process 5 Part I environmental responsibility six
conserve energy ,reduce emissions…… six
Pollutant discharge eight
Emergency plan for environmental events 9 Part II social responsibility ten
Actively and legally pay taxes ten
Employment equality and employment compliance eleven
Safe production thirteen
Occupational health and epidemic prevention and control fourteen
Help Henan flood rescue Part III governance responsibilities eighteen
Implementation of equity incentive twenty
Improve the internal control system twenty
Anti corruption, anti commercial bribery, anti unfair competition twenty
Promote strategic innovation and intellectual property layout twenty-one
Customer responsibility and supplier management 21 key Kay
Jenkem Technology Co.Ltd(688356) (stock code Jenkem Technology Co.Ltd(688356) , stock abbreviation Jenkem Technology Co.Ltd(688356) , hereinafter referred to as ” Jenkem Technology Co.Ltd(688356) ” and “company”) is a high-tech enterprise dedicated to the industrialization of medical polyethylene glycol derivatives, registered in Haidian District, Beijing, and landed on the science and Innovation Board of Shanghai Stock Exchange on August 26, 2020. At present, the company has built a development and industrialization base of medical polyethylene glycol derivatives covering an area of more than 15000 square meters in the biomedical park in the West District of Tianjin Development Zone, and has built a R & D and automatic production line of high-purity medical polyethylene glycol materials in Panjin Fine Chemical Industrial Park, Liaoning Province.
At present, the company and its subsidiaries Tianjin Jenkem Technology Co.Ltd(688356) Co., Ltd. and Liaoning Jenkem Technology Co.Ltd(688356) Co., Ltd. have obtained the certification of high-tech enterprises. It is one of the few companies outside China that can carry out the industrial production of medical polyethylene glycol and active derivatives with high purity and low dispersion, filling the gap of China’s long-term lack of high-quality medical polyethylene glycol and its derivatives, It is also a major emerging player in the global market. As of December 31, 2021, Jenkem Technology Co.Ltd(688356) has obtained 87 Chinese and world invention patents, and another 45 patents are under application.
Jenkem Technology Co.Ltd(688356) has supported the R & D and production of four polyethylene glycol modified drugs listed in China; It provides several international pharmaceutical enterprises with medical polyethylene glycol and its active derivatives required for the production of three types of medical devices. In addition, the company has also supported dozens of phase II and III clinical projects of many Chinese international pharmaceutical enterprises and medical device enterprises, cooperated with hundreds of well-known universities or scientific research institutes outside China, and more than 700 Chinese international papers cited Jenkem Technology Co.Ltd(688356) and Jiankai products.
Project 20212020 2019
Operating income (10000 yuan) 351190618662261343196
Net profit (10000 yuan) 1757801856789615437
Employees 208153 139
The vision of Jiankai culture enterprise is to be a leading enterprise in the field of medical and pharmaceutical pan polyethylene glycol materials in the world, focus on creating specialty, achieve the future enterprise mission with specialty, lead biomedical innovation with material innovation, help the biomedical industry to continue to shine and heat, protect the health of all mankind, constantly innovate enterprise values, forge ahead, respect science and respect talents, and take the field of Pan polyethylene glycol materials as the core, Realize China’s international double cycle and double drive of material sales and technical service. The slogan of the enterprise comes from the heart
Jenkem Technology Co.Ltd(688356) social responsibility management system
Jenkem Technology Co.Ltd(688356) adhering to the concept of “leading biomedical innovation with material innovation” and taking boosting the development of human health as the highest mission, the company uses social responsibility management system to promote the high-quality development of the company, strictly control product quality and safety responsibilities, continue to promote R & D work conducive to improving life value and quality, and adhere to honest operation and fair competition, Put the concept of sustainability through all aspects of enterprise operation and continue to improve.
On the basis of achieving the company’s business objectives with high quality, Jenkem Technology Co.Ltd(688356) emphasizes people-oriented, takes improving people’s well-being as the ultimate goal of some economic activities of the company, does a good job in the enterprise and gives back to the society with love. In the future, Jiankai will continue to work with the government, shareholders, employees, upstream and downstream partners to jointly promote the realization of the goal of “health for all” in a well-off society and move towards a better life and future.
At the end of 2021, Jenkem Technology Co.Ltd(688356) officially began to incorporate the performance of social responsibility into the enterprise development strategy. The company has established a social responsibility management system under the leadership of the board of directors and the division and cooperation of relevant functional departments, so as to better promote the sustainable development of the company in terms of environment, society and governance. Analysis of substantive issues and participation of relevant stakeholders
Jenkem Technology Co.Ltd(688356) ‘s social responsibility management system is led and organized by the office of the board of directors, which attaches importance to good communication with relevant parties and evaluates the importance of issues concerned by the company and all relevant parties to the sustainable development of the enterprise, so as to serve as a reference basis for the company’s performance of social responsibility and future improvement, and maintain the sustainability of this relationship.
Jenkem Technology Co.Ltd(688356) communicate with stakeholders on the following issues:
Response methods of relevant departments responsible for stakeholder issues
The general management department of compliance operation of the government shall pay taxes according to law
The finance department shall publicize regularly
EHS department insists on legal and compliant operation
The production department of product safety and quality of downstream customers continues to improve the construction of quality system
The data integrity and traceability quality department insists on fair competition
The R & D department shall obtain the necessary qualifications
Business Ethics (anti commercial bribery) marketing department enriches customer feedback channels
Regular visit and satisfaction survey of Sales Department
Dispute resolution and strategic cooperation of Finance Department
Internal audit department
The board of directors of employee compensation and welfare shall establish a fair and transparent recruitment system and the performance appraisal system of the human resources department
The occupational health and safety EHS department provides competitive remuneration and benefits
The comprehensive management department of career development supports employees to voluntarily participate in on-the-job training, create a comfortable office environment with equality and anti discrimination, and build a garden factory with flower salary and assessment system
Integrity procurement of upstream supplier’s product safety and quality procurement department
Business Ethics (anti commercial bribery) strategic cooperation of Finance Department
Improve communication channels with the internal audit department (unfair competition)
Disputes and settlement
Structure of the board of directors of shareholders (including the board of directors) and periodic report of the board of directors
Institutional investors and China equity structure securities affairs department information disclosure compliance
Small investors) financial statements performance exchange meeting of the financial department
Business Ethics (the internal audit department against commercial bribery constantly improves the level of corporate governance and establishes a sound management system against unfair competition)
capital operation
Industrial new technology issues and strategic cooperation with industrial development and R & D department
Exhibition direction
